Statin Studies May Dampen Enthusiasm For Cost-Effectiveness Trials – AARP

Results of the head-to-head comparison of Pfizer's Lipitor and Bristol-Myers Squibb's Pravachol may reduce industry's enthusiasm for comparative studies, AARP CEO Bill Novelli said